Michael G. Kauffman
2021
In 2021, Michael G. Kauffman earned a total compensation of $3.1M as Senior Clinical Advisor and Former Chief Executive Officer at Karyopharm Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $237,188 |
|---|---|
| Option Awards | $1,507,217 |
| Salary | $474,375 |
| Stock Awards | $832,832 |
| Other | $17,977 |
| Total | $3,069,589 |
Kauffman received $1.5M in option awards, accounting for 49% of the total pay in 2021.
Kauffman also received $237.2K in non-equity incentive plan, $474.4K in salary, $832.8K in stock awards and $18K in other compensation.
Rankings
In 2021, Michael G. Kauffman's compensation ranked 4,338th out of 12,405 executives tracked by ExecPay. In other words, Kauffman earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,338 out of 12,405 | 65th |
Division Manufacturing | 1,787 out of 5,494 | 68th |
Major group Chemicals And Allied Products | 751 out of 2,369 | 68th |
Industry group Drugs | 670 out of 2,090 | 68th |
Industry Pharmaceutical Preparations | 475 out of 1,537 | 69th |
Source: SEC filing on April 8, 2022.
Kauffman's colleagues
We found five more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2021.
2021
Richard Paulson
Karyopharm Therapeutics
Chief Executive Officer
2021
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
2021
Michael Mason
Karyopharm Therapeutics
Chief Financial Officer
2021
Jatin Shah
Karyopharm Therapeutics
Chief Medical Officer
2021
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Chief Development Officer
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019